Notice of Zhaoyan Pharmaceutical on holding the first extraordinary general meeting of shareholders in 2025, the first A-share shareholders\' meeting in 2025, and the first H-share shareholders\' meeting in 2025
Information on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan Pharmaceutical, the first Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on the resignation of directors and by-election of directors
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of a fund
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in investment funds
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Zhaoyan Pharmaceutical: Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of an industrial fund
Zhaoyan Pharmaceutical: Announcement of Beijing Zhaoyan New Drug Research Center Co., Ltd. on changing the company\'s registered capital and amending the company\'s articles of association
Zhaoyan New Pharmaceutical: Announcement of Zhaoyan New Pharmaceutical on the Resignation of Directors and the By-election of Non-Independent Directors
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. on changing the registered capital of the company and amending the company\'s articles of association
Announcement of Zhaoyan New Pharmaceutical on cooperating with professional investment institutions to participate in the establishment of industrial funds
Announcement of Zhaoyan Pharmaceutical regarding the resignation of directors and by-election of non-independent directors
Zhaoyan Pharmaceutical: Zhaoyan Pharmaceutical\'s progress announcement on the repurchase of the company\'s A-share shares through centralized bidding transactions
Resolutions of the 2nd Special Meeting of Independent Directors of Zhaoyan Pharmaceutical in 2024
Announcement of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd. to increase the capital of its wholly-owned overseas subsidiaries
Joinn Laboratories' Announcement on the Progress of Collaborating with Professional Investment Institutions to Participate in the Establishment of Industrial Funds and Related Trades
Announcement of resolutions of 2023 annual general meeting of shareholders, 2024 second A-share category shareholders' meeting and 2024 second H-share category shareholders' meeting of Joinn Laboratories.
Legal opinion of Tianyuan Law Firm on the 2023 annual shareholders' meeting, 2024 second A-share category shareholder meeting and 2024 second listed in Hong Kong category shareholder meeting of Joinn Laboratories.
Information on the 2023 Annual General Meeting of Shareholders of Zhaoyan Pharmaceutical, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Notice of Zhaoyan Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024